Vancomycin Ophthalmic Solutions Recalled for Sterility Assurance Concerns
Pharmacy Innovations is recalling vancomycin fortified ophthalmic solutions nationwide due to lack of sterility assurance. FDA inspection revealed insanitary conditions at the manufacturing facility.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: Scores as High: involves a risk-of-harm product category (ophthalmic medications) where no injuries have been reported, matching the High severity criterion. FDA Class II classification with documented insanitary facility conditions reinforces this assessment.
Plain-English summary
Pharmacy Innovations is recalling multiple strengths of vancomycin fortified ophthalmic solutions distributed nationwide. The recalled products include vancomycin fortified 10 mg/mL (1 mL droptainer), vancomycin fortified 14 mg/mL (3 mL droptainer), vancomycin fortified-STS 50 mg/mL, and vancomycin-STS 25 mg/mL (2 mL droptainer) formulations.
The recall was initiated due to lack of assurance of sterility. FDA inspection of the manufacturing facility in Erie, Pennsylvania revealed insanitary conditions that could affect the sterility of the products.
The affected products were distributed nationwide. Lot codes associated with the recall include t20221122@15, t20221110@28, t20221027@33, and t20221020@5. These are prescription-only products that may have been dispensed through pharmacies.
Consumers and healthcare providers who have obtained these products should stop using them and consult with their healthcare provider regarding alternative treatment options.
The recalled product
- Product
- VANCOMYCIN FORTIFIED 10MG/ML (1ML DROPTAINER) OPH SOLUTION VANCOMYCIN FORTIFIED 14MG/ML (3ML DROPTAINER) OPH SOLUTION VANCOMYCIN FORTIFIED-STS- 50MG/ML OPH SOLUTION VANCOMYCIN-STS- 25MG/ML (2ML DROPTAINER) OPH SOLUTION, Rx Only, Pharmacy Innovations, 2936 W 17th St., Erie, PA.
- Manufacturer
- Pharmacy Innovations
- Category
- Drug — Ophthalmic
- Hazard
- lack-of-sterility
- contamination-risk
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- t20221122@15 t20221110@28 t20221027@33 t20221020@5
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27